Key result
Factor Xa inhibitors are emerging as safe and effective options for venous thromboembolism prevention in patients with cancer undergoing abdominal surgery.
Why the study?
Are Factor Xa inhibitors safe and effective for VTE prevention in patients with cancer undergoing abdominal surgery?
Population
Patients with cancer undergoing major abdominal surgery
Design
Review
Authors
Loading...
May support VTE prophylaxis consideration in this population; leaves open need for randomized confirmation before practice change.
Are Factor Xa inhibitors safe and effective for VTE prevention in patients with cancer undergoing abdominal surgery?
Factor Xa inhibitors represent an emerging, safe, and effective option for VTE prophylaxis in cancer patients undergoing major abdominal surgery.
Agnelli et al. (2007) conducted a review in Venous thromboembolism in patients with cancer undergoing major abdominal surgery. Factor Xa inhibitors was evaluated. Factor Xa inhibitors are emerging as safe and effective options for venous thromboembolism prevention in patients with cancer undergoing abdominal surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: